Show simple item record

dc.contributor.authorSenga, SS
dc.contributor.authorGrose, RP
dc.date.accessioned2021-04-14T16:04:01Z
dc.date.available2021-04-14T16:04:01Z
dc.date.issued2021-01-20
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/71269
dc.description.abstractDiagnosis and treatment of disease demand a sound understanding of the underlying mechanisms, determining any Achilles' heel that can be targeted in effective therapies. Throughout history, this endeavour to decipher the origin and mechanism of transformation of a normal cell into cancer has led to various theories-from cancer as a curse to an understanding at the level of single-cell heterogeneity, meaning even among a single sub-type of cancer there are myriad molecular challenges to overcome. With increasing insight into cancer genetics and biology, the disease has become ever more complex to understand. The complexity of cancer as a disease was distilled into key traits by Hanahan and Weinberg in their seminal 'Hallmarks of Cancer' reviews. This lucid conceptualization of complex cancer biology is widely accepted and has helped advance cancer therapeutics by targeting the various hallmarks but, with the advancement in technologies, there is greater granularity in how we view cancer as a disease, and the additional understanding over the past decade requires us to revisit the hallmarks of cancer. Based on extensive study of the cancer research literature, we propose four novel hallmarks of cancer, namely, the ability of cells to regress from a specific specialized functional state, epigenetic changes that can affect gene expression, the role of microorganisms and neuronal signalling, to be included in the hallmark conceptualization along with evidence of various means to exploit them therapeutically.en_US
dc.format.extent200358
dc.languageeng
dc.publisherRoyal Society Publishingen_US
dc.relation.ispartofOpen Biology
dc.rightsPublished by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
dc.subjectcancer hallmarksen_US
dc.subjectde-differentiationen_US
dc.subjectepigeneticsen_US
dc.subjectmicrobiomeen_US
dc.subjectneuronal signallingen_US
dc.titleHallmarks of cancer-the new testament.en_US
dc.typeArticleen_US
dc.rights.holder© 2021 The Authors.
dc.identifier.doi10.1098/rsob.200358
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/33465324en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttps://doi.org/10.1098/rsob.200358
pubs.volume11en_US
dcterms.dateAccepted2020-12-10
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record